Form D · Biotechnology
Neogenix Oncology Inc
Great Neck, NY · CIK 0001341293
Offering snapshot reported Oct 8, 2010 · SEC filing
- Reported sold
- $846K Offering amount: $40M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $300K Reported outside-investor minimum
- First sale
- Sep 30, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 8, 2010 | Initial | $846,225 | No comparison | 16 | SEC filing |
| Dec 15, 2009 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| May 22, 2009 | Initial | Yet to sell | No comparison | Not reported | SEC filing |
| May 15, 2009 | Initial | $15,000,000 | No comparison | Not reported | SEC filing |
| May 1, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 11, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-148803
Source: Form D, filed Oct 8, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Phillip Arlen | Director, Executive |
| Philip Arlen | Director, Executive |
| Myron Arlen | Director, Executive, Promoter |
| William Ashton | Director |
| James Feldman | Director |
| Barry Gause | Director |
| Peter Gordon | Director, Executive, Promoter |
| Dennis Greene | Director |
| Rishab Gupta | Executive |
| J. Douglas Holladay | Director |
| Lynn Krominga | Director |
| Thomas Lytle | Director, Executive |
| David S. Moskowitz | Director |
| Timothy P. Shriver | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
445 Northern Boulevard
Great Neck, NY, 11021
Great Neck, NY, 11021